Takeda, U.S. Department of Health and Human Services infectious news

HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Takeda a contract worth up to $312 million to develop an inactivated, adjuvanted, whole Zika virus vaccine. Takeda will rec...